Company / Total Assets
Fortress Biotech, Inc. Total Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$185.5M
FY2025
5-year range
$144.2M / $396.5M
FY2021-FY2025
Trend
+28.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Total Assets returned to growth in FY2025 after 3 years of decline, reaching $186M.
Based on SEC 10-K filings.
$186M in FY2025 with a 5-year CAGR of -3.9%.
Improved from $168M to $186M over the past 2 years.
Total Assets over time
Growth rates
- 3-Year CAGR
- -14.3%
- 5-Year CAGR
- -3.9%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -3.9%, indicating a declining trend.
- In FY2025, total assets increased 28.7% year-over-year.
- Peak total assets was recorded in FY2021.
- Lowest total assets in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -1.10 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $185.5M | +28.7% |
| FY2024 | $144.2M | -13.9% |
| FY2023 | $167.5M | -43.1% |
| FY2022 | $294.3M | -25.8% |
| FY2021 | $396.5M | +75.1% |
| FY2020 | $226.4M | +0.0% |
| FY2019 | $226.4M | +60.6% |
| FY2018 | $141.0M | -42.7% |
| FY2017 | $245.9M | +107.4% |
| FY2016 | $118.6M | +0.0% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026